Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Adie Viljoen & Anthony S Wierzbicki. (2012) Diagnosis and treatment of severe hypertriglyceridemia. Expert Review of Cardiovascular Therapy 10:4, pages 505-514.
Read now
Read now
Ali Elgalib, Michael Aboud, Ranjababu Kulasegaram, Caroline Dimian, Alastair Duncan, Anthony S. Wierzbicki & Barry S. Peters. (2011) The assessment of metabolic syndrome in UK patients with HIV using two different definitions: CREATE 2 study. Current Medical Research and Opinion 27:1, pages 63-69.
Read now
Read now
Mazen S. Bader & Deborah V. Kelly. (2008) Diagnosis and Management of Common Chronic Metabolic Complications in HIV-infected Patients. Postgraduate Medicine 120:4, pages 17-27.
Read now
Read now
Articles from other publishers (27)
Kehinde Sola Akinlade, Eni Bassey Bernard, Okechukwu Samuel Ogah & Sheu Kadiri Rahamon. (2021) Serum levels of adiponectin, resistin and tumour necrosis factor-alpha in Nigerian men with nuchal fat fold. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15:5, pages 102214.
Crossref
Crossref
Habib Yaribeygi, Farin Rashid Farrokhi, Alexandra E. Butler & Amirhossein Sahebkar. (2018) Insulin resistance: Review of the underlying molecular mechanisms. Journal of Cellular Physiology 234:6, pages 8152-8161.
Crossref
Crossref
Dominica Hernandez, Seth C. Kalichman, Harold P. Katner, Kaylee Burnham, Moira O. Kalichman & Marnie Hill. (2018) Psychosocial complications of HIV/AIDS-metabolic disorder comorbidities among patients in a rural area of southeastern United States. Journal of Behavioral Medicine 41:4, pages 441-449.
Crossref
Crossref
Oluwafeyisetan Adebiyi, Olubunmi Adebiyi & Peter Owira. (2015) Naringin Reverses Hepatocyte Apoptosis and Oxidative Stress Associated with HIV-1 Nucleotide Reverse Transcriptase Inhibitors-Induced Metabolic Complications. Nutrients 7:12, pages 10352-10368.
Crossref
Crossref
Mary-Ann Davies, Jorge Pinto & Marlène Bras. (2015) Getting to 90-90-90 in paediatric HIV: What is needed?. Journal of the International AIDS Society 18, pages 20770.
Crossref
Crossref
Rachel C Vreeman, Michael L Scanlon, Megan S McHenry & Winstone M Nyandiko. (2015) The physical and psychological effects of HIV infection and its treatment on perinatally HIV-infected children. Journal of the International AIDS Society 18, pages 20258.
Crossref
Crossref
Jonathan Buckley & Peter Howe. (2015) An Update from the Editorial Board of Nutrients. Nutrients 7:7, pages 5540-5541.
Crossref
Crossref
Mario González-Sales, Olivier Barrière, Pierre Olivier Tremblay, Fahima Nekka, Jean-Claude Mamputu, Sylvie Boudreault & Mario Tanguay. (2014) Population Pharmacokinetic Analysis of Tesamorelin in HIV-Infected Patients and Healthy Subjects. Clinical Pharmacokinetics 54:3, pages 285-294.
Crossref
Crossref
Mansueto Gomes Neto, Ricardo Zwirtes & Carlos Brites. (2013) A literature review on cardiovascular risk in human immunodeficiency virus-infected patients: implications for clinical management. The Brazilian Journal of Infectious Diseases 17:6, pages 691-700.
Crossref
Crossref
Barry S. Peters, Melissa Perry, Anthony S. Wierzbicki, Lisa E. Wolber, Glen M. Blake, Nishma Patel, Richard Hoile, Alastair Duncan, Ranjababu Kulasegaram & Frances M. K. Williams. (2013) A Cross-Sectional Randomised Study of Fracture Risk in People with HIV Infection in the Probono 1 Study. PLoS ONE 8:10, pages e78048.
Crossref
Crossref
Debra E. Lyon. (2010) Review: Women living with HIV/AIDS and the bodily transformation process known as lipodystrophy: a grounded theory study. Journal of Research in Nursing 17:3, pages 229-230.
Crossref
Crossref
Marilou Gagnon & Dave Holmes. (2010) Women living with HIV/AIDS and the bodily transformation process known as the lipodystrophy syndrome: a grounded theory study. Journal of Research in Nursing 17:3, pages 215-228.
Crossref
Crossref
Giancarlo Ceccarelli, Gabriella d'Ettorre, Francesco Marchetti, Cecilia Rizza, Claudio M Mastroianni, Bruno Carlesimo & Vincenzo Vullo. (2011) Development of Buffalo Hump in the course of antiretroviral therapy including raltegravir and unboosted atazanavir: a case report and review of the literature. Journal of Medical Case Reports 5:1.
Crossref
Crossref
Nicolai Lohse, Jan Gerstoft, Gitte Kronborg, Carsten Schade Larsen, Court Pedersen, Gitte Pedersen, Lars Nielsen, Henrik Toft Sørensen & Niels Obel. (2011) Comorbidity Acquired Before HIV Diagnosis and Mortality in Persons Infected and Uninfected With HIV: A Danish Population-Based Cohort Study. JAIDS Journal of Acquired Immune Deficiency Syndromes 57:4, pages 334-339.
Crossref
Crossref
Sohita Dhillon. (2011) Tesamorelin. Drugs 71:8, pages 1071-1091.
Crossref
Crossref
B.S. Peters & K. Conway. (2011) Therapy for HIV. Advances in Dental Research 23:1, pages 23-27.
Crossref
Crossref
M. Aboud, A. Elgalib, L. Pomeroy, G. Panayiotakopoulos, E. Skopelitis, R. Kulasegaram, C. Dimian, F. C Lampe, A. Duncan, A. S. Wierzbicki & B. S. Peters. (2010) Cardiovascular risk evaluation and antiretroviral therapy effects in an HIV cohort: implications for clinical management: the CREATE 1 study. International Journal of Clinical Practice 64:9, pages 1252-1259.
Crossref
Crossref
Lloyd Einsiedel, Catherine L. Cherry, Freya L. Sheeran, Anna Friedhuber, Steve L. Wesselingh & Salvatore Pepe. (2010) Mitochondrial dysfunction in CD4+lymphocytes from stavudine-treated HIV patients. Mitochondrion 10:5, pages 534-539.
Crossref
Crossref
A. S. Wierzbicki & B. S. Peters. (2010) Putting protection first: vascular risk assessment in atypical populations. International Journal of Clinical Practice 64:6, pages 664-666.
Crossref
Crossref
Lorraine V. Kalia, Liesly Lee, Suneil K. Kalia, Farhad Pirouzmand, Mark J. Rapoport, Richard I. Aviv, Dan Mozeg & Sean P. Symons. (2014) Thoracic Myelopathy from Coincident Fluorosis and Epidural Lipomatosis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 37:2, pages 276-278.
Crossref
Crossref
Anthony S. Wierzbicki & Adie Viljoen. (2010) Hyperlipidaemia in Paediatric Patients. Drug Safety 33:2, pages 115-125.
Crossref
Crossref
K. A. Finucane & C. B. Archer. (2010) Dermatological aspects of medicine: highly active antiretroviral therapy and the treatment of human immunodeficiency virus. Clinical and Experimental Dermatology 35:1, pages 107-109.
Crossref
Crossref
Esther CabreroLaura GriffaAngel Burgos. (2010) Prevalence and Impact of Body Physical Changes in HIV Patients Treated with Highly Active Antiretroviral Therapy: Results from a Study on Patient and Physician Perceptions. AIDS Patient Care and STDs 24:1, pages 5-13.
Crossref
Crossref
Sang Hoon Han, Bum Sik Chin, Han Sung Lee, Su Jin Jeong, Hee Kyoung Choi, Chang Oh Kim, Jun Yong Choi, Young Goo Song, Hyun Chul Lee & June Myung Kim. (2009) Serum retinol-binding protein 4 correlates with obesity, insulin resistance, and dyslipidemia in HIV-infected subjects receiving highly active antiretroviral therapy. Metabolism 58:11, pages 1523-1529.
Crossref
Crossref
J. C K Wells. (2008) Ethnic variability in adiposity and cardiovascular risk: the variable disease selection hypothesis. International Journal of Epidemiology 38:1, pages 63-71.
Crossref
Crossref
Sang Hoon Han, Bum Sik Chin, Hee Kyoung Choi, So Youn Shin, Yun Tae Chae, Ji-Hyeon Baek, Chang Oh Kim, Jun Yong Choi, Young Goo Song, Hyun Chul Lee & June Myung Kim. (2009) Prevalence of and Clinical Factors Associated with Lipoatrophy in HIV-Infected Koreans Receiving Highly Active Antiretroviral Therapy. The Tohoku Journal of Experimental Medicine 219:2, pages 145-153.
Crossref
Crossref
Anthony S WierzbickiScott D Purdon, Timothy C Hardman, Ranjababu Kulasegaram & Barry S Peters. (2008) Review: Clinical aspects of the management of HIV lipodystrophy. The British Journal of Diabetes & Vascular Disease 8:3, pages 113-119.
Crossref
Crossref